SCHEMBL22730232

SCHEMBL22730232

CC[Si](Cl)(C(C)(C)Cc1ccccc1)C(C)(C)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.40
SLC6A2 P23975 1/20 0.40
CYP1A2 P05177 3/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
LMNA P02545 1/20 0.38
CYP2D6 P10635 1/20 0.38
KCNA5 P22460 1/20 0.35
CYP3A4 P08684 2/20 0.35
RECQL P46063 1/20 0.35
TRPA1 O75762 1/20 0.34
KIF11 P52732 3/20 0.34
MAPK1 P28482 1/20 0.34
TP53 P04637 1/20 0.33
CYP19A1 P11511 1/20 0.33
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22730201 0.84 TAAR1 (0.35) TAAR1CYP2C19CYP3A4MAPK1TSHR
SCHEMBL22730251 0.84 TAAR1 (0.40) TAAR1CYP2C19CYP3A4MAPK1TSHR
SCHEMBL22730156 0.80 TAAR1 (0.38) TAAR1CYP2C19CYP3A4MAPK1TSHR
SCHEMBL22730168 0.79 TAAR1 (0.42) TAAR1SLC6A2CYP1A2CYP2C9CYP2C19
SCHEMBL22730153 0.77 TAAR1 (0.35) TAAR1CYP2C19CYP3A4KIF11MAPK1
SCHEMBL22730162 0.77 TAAR1 (0.40) TAAR1SLC6A2CYP1A2CYP2C9CYP2C19
SCHEMBL22730226 0.77 TAAR1 (0.40) TAAR1SLC6A2CYP1A2CYP2C9CYP2C19
SCHEMBL22730209 0.75 CYP2C19 (0.34) TAAR1CYP1A2CYP2C19CYP2D6KIF11
SCHEMBL6889501 0.74 SLC6A2 (0.52) TAAR1SLC6A2CYP1A2CYP2C9CYP2C19
SCHEMBL22730237 0.72 TAAR1 (0.42) TAAR1SLC6A2CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066427-B2 Organosilane compounds having bulky substituent and preparation thereof SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-07-20 US disclosed
US-20200385411-A1 ORGANOSILANE COMPOUNDS HAVING BULKY SUBSTITUENT AND PREPARATION THEREOF SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-12-10 US disclosed
EP-3747889-A1 ORGANOSILANE COMPOUNDS HAVING BULKY SUBSTITUENT AND PREPARATION THEREOF Shin-Etsu Chemical Co., Ltd. (JP) 2020-12-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11066427-B2 Organosilane compounds having bulky substituent and preparation thereof C1S, C1R, C9 TAAR1 1233/4885SLC6A2 4250/4885CYP1A2 93/4885
US-20200385411-A1 ORGANOSILANE COMPOUNDS HAVING BULKY SUBSTITUENT AND PREPARATION THEREOF C1S, C1R, C9 TAAR1 1233/4885SLC6A2 4250/4885CYP1A2 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.